Contact Us

Alzheimer’s drug granted accelerated approval by FDA. These are the risks

Thought Leader: Sanjay Gupta
January 7, 2023
Source: CNN
CNN’s Sanjay Gupta reports the US Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug Lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Speaker List
Share My List